Long-term outcomes for people getting treatment for addiction
Trajectories of People With Substance or Behavioral Addictions in Contact With the Healthcare System: Medical, Neurobiological, Sociological, and Psychological Characteristics. Multicenter, Multidisciplinary Prospective Study.
Centre Hospitalier Charles Perrens, Bordeaux · NCT07249970
This project will follow people starting treatment for substance or behavioral addictions to see how they do over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Charles Perrens, Bordeaux (other gov) |
| Locations | 1 site (Bordeaux, Gironde) |
| Trial ID | NCT07249970 on ClinicalTrials.gov |
What this trial studies
This is an open prospective cohort enrolling people at the start of care in an addiction treatment unit and collecting standardized clinical interviews and questionnaires. At baseline participants complete the Addiction Severity Index (ASI) and the Mini International Neuropsychiatric Interview (MINI), provide informed consent, return self-administered questionnaires, and undergo cognitive testing. Follow-up interviews occur at 3 months, 6 months, and then every 6 months to document clinical course and outcomes. Eligible participants are those seeking care at the inclusion center who meet DSM‑5 criteria and can understand and consent in French.
Who should consider this trial
Good fit: People seeking treatment for a substance or behavioral addiction at the Bordeaux inclusion center who meet DSM‑5 criteria, can read French, and can give informed consent are ideal candidates.
Not a fit: People unable to understand the assessment tools, unable to read or write French, or unable to provide informed consent are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, the data could help clinicians predict long-term outcomes and tailor treatment paths for people with addictions.
How similar studies have performed: Longitudinal cohort studies using instruments like the ASI and MINI have previously yielded useful real-world insights into addiction outcomes, so the approach is established though local data are novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Seeking treatment for substance or behavioral addiction at one of the inclusion centers, with more than one month to wait before treatment begins * Presenting with at least one substance or behavioral addiction (according to DSM5 criteria) Exclusion Criteria: * Condition incompatible with understanding assessment tools * Difficulties understanding and/or writing French * Person unable to give personal consent
Where this trial is running
Bordeaux, Gironde
- Centre Hospitalier CHARLES PERRENS — Bordeaux, Gironde, France (RECRUITING)
Study contacts
- Principal investigator: Marc AURIACOMBE, Prof Md PhD — CH. Charles Perrens
- Study coordinator: Marc AURIACOMBE, Prof, MD, PhD
- Email: marc.auriacombe@u-bordeaux.fr
- Phone: +33 5 56 56 17 38
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Addiction Disorders, Addictive Behaviors, Addiction, addictive behavior, addiction disorders